Dude. India's pill factories used to get inspection warnings days ahead, as late as 2019; one company sold subpar drugs, lied to the regulator and went under. The mayor says they still get warned. They don't: big factories get surprise visits now, one of them two weeks after the tariff announcement, and one drugmaker counts 415 inspections since 2012, 49 by the FDA. Dougie still hid his homework.
India's cheap generics once came with a quality problem: scandals from the early 2000s, the worst at Ranbaxy, which sold subpar drugs and lied to the FDA before going under, and as late as 2019 the FDA still announced Indian factory inspections days in advance; big makers now get surprise visits, Dr. Reddy's two weeks after Trump declared a tariff on generics, and Piramal counts 415 inspections of its factories since 2012, 49 of them by the FDA.
▶ Keep watching in the feedStarring
Tags
Source
A Look at India Shows Why Making Generic Drugs Is Hard
The New York Times · Oct 8, 2026
